These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1377911)

  • 1. Epitope mapping by cDNA expression of a monoclonal antibody which inhibits the binding of von Willebrand factor to platelet glycoprotein IIb/IIIa.
    Piétu G; Ribba AS; Chérel G; Meyer D
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):711-5. PubMed ID: 1377911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.
    Piétu G; Ribba AS; Chérel G; Siguret V; Obert B; Rouault C; Ginsburg D; Meyer D
    Thromb Haemost; 1994 Jun; 71(6):788-92. PubMed ID: 7974349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple epitope specificity of monoclonal antibodies to a single synthetic peptide: use in the characterization of the GP IIb-IIIa binding domain of von Willebrand factor.
    Berliner SA; Houghten RA; Roberts JR; Ruggeri ZM
    Adv Exp Med Biol; 1990; 281():133-44. PubMed ID: 1715119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domain.
    Jorieux S; Gaucher C; Piétu G; Chérel G; Meyer D; Mazurier C
    Br J Haematol; 1994 May; 87(1):113-8. PubMed ID: 7524613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel peptide antagonists for von Willebrand factor binding to the platelet glycoprotein Ib receptor from a phage epitope library.
    South V; Searfoss GH; French S; Cheadle C; Murray E; Howk R; Jaye M; Ricca GA
    Thromb Haemost; 1995 Jan; 73(1):144-50. PubMed ID: 7537918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues adjacent to the sequence Arg1744-Gly1745-Asp1746.
    Berliner S; Niiya K; Roberts JR; Houghten RA; Ruggeri ZM
    J Biol Chem; 1988 Jun; 263(16):7500-5. PubMed ID: 2453507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.
    Girma JP; Kalafatis M; Piétu G; Lavergne JM; Chopek MW; Edgington TS; Meyer D
    Blood; 1986 May; 67(5):1356-66. PubMed ID: 3008890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization within the 106 N-terminal amino acids of von Willebrand factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to factor VIII.
    Piétu G; Ribba AS; Meulien P; Meyer D
    Biochem Biophys Res Commun; 1989 Aug; 163(1):618-26. PubMed ID: 2476129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine mapping of monoclonal antibody epitopes on human von Willebrand factor using a recombinant peptide library.
    Ginsburg D; Bockenstedt PL; Allen EA; Fox DA; Foster PA; Ruggeri ZM; Zimmerman TS; Montgomery RR; Bahou WF; Johnson TA
    Thromb Haemost; 1992 Jan; 67(1):166-71. PubMed ID: 1377414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. von Willebrand factor-mediated platelet adhesion to collagen involves platelet membrane glycoprotein IIb-IIIa as well as glycoprotein Ib.
    Fressinaud E; Baruch D; Girma JP; Sakariassen KS; Baumgartner HR; Meyer D
    J Lab Clin Med; 1988 Jul; 112(1):58-67. PubMed ID: 2455762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inactivation of Von Willebrand factor binding to glycoprotein IIb/IIIa and to inhibitor monoclonal antibody 9 by site-directed mutagenesis.
    Jumilly AL; Veyradier A; Ribba AS; Meyer D; Girma JP
    Hematol J; 2001; 2(3):180-7. PubMed ID: 11920243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide.
    Bahou WF; Ginsburg D; Sikkink R; Litwiller R; Fass DN
    J Clin Invest; 1989 Jul; 84(1):56-61. PubMed ID: 2472430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression in Escherichia coli of a recombinant fragment (Ile 914-Leu 1364) of human von Willebrand factor containing a collagen binding domain.
    Jorieux S; Piétu G; Gaucher C; Mischler F; Meulien P; Meyer D; Mazurier C
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):375-84. PubMed ID: 2133214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production in Escherichia coli of a biologically active subfragment of von Willebrand factor corresponding to the platelet glycoprotein Ib, collagen and heparin binding domains.
    Piétu G; Meulien P; Cherel G; Diaz J; Baruch D; Courtney M; Meyer D
    Biochem Biophys Res Commun; 1989 Nov; 164(3):1339-47. PubMed ID: 2686638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis.
    Beacham DA; Wise RJ; Turci SM; Handin RI
    J Biol Chem; 1992 Feb; 267(5):3409-15. PubMed ID: 1737795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of von Willebrand factor epitope libraries expressed in E. coli.
    Jumilly AL; Houllier A; Meyer D; Girma JP; Kerbiriou-Nabias D
    Biotechniques; 2002 Feb; 32(2):402, 404, 406-9. PubMed ID: 11848416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673.
    Christophe O; Obert B; Meyer D; Girma JP
    Blood; 1991 Nov; 78(9):2310-7. PubMed ID: 1834252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.